Two Different Types of Renal Involvement in Tuberous Sclerosis Complex

Author(s):  
F. Scolari ◽  
B.F. Viola ◽  
L. Grazioli ◽  
L. Longa ◽  
N. Migone ◽  
...  
1994 ◽  
Vol 8 (4) ◽  
pp. 451-457 ◽  
Author(s):  
L. B. Zimmerhackl ◽  
M. Rehm ◽  
K. Kaufmehl ◽  
G. Kurlemann ◽  
M. Brandis

2009 ◽  
Vol 72 (2) ◽  
pp. 335-341 ◽  
Author(s):  
Giovanni Pompili ◽  
Salvatore Zirpoli ◽  
Chiara Sala ◽  
Nicola Flor ◽  
Rosa Maria Alfano ◽  
...  

2014 ◽  
Vol 13 (1) ◽  
pp. e318-e318a ◽  
Author(s):  
J.C. Kingswood ◽  
D. Demuth ◽  
P. Nasuti ◽  
L. Lucchese ◽  
E. Gray ◽  
...  

2021 ◽  
Author(s):  
Efthymia Vargiami ◽  
Stella Stabouli ◽  
Christina Sidira ◽  
Maria Kyriazi ◽  
Athanasia Anastasiou ◽  
...  

Abstract Background Renal involvement is very common in tuberous sclerosis complex (TSC) and is characterised by the development of angiomyolipoma and cysts. The aims of the present study were to assess kidney function and clinical features of renal involvement in TSC, including kidney function, and blood pressure (BP) levels in children, adolescents and young adults. Methods Non-selected patients with a definite diagnosis of TSC attending the paediatric neurology outpatient department of a tertiary hospital were included in a cross-sectional study. All participants had a renal imaging study within 6 months of ambulatory blood pressure (BP) and glomerular filtration rate (GFR) assessment. Data on demographics, history, genotype, kidney function at diagnosis and last imaging were collected. Results The median age of the patients was 15 years (IQR range 9 to18). 23.5% of the participants had ambulatory BP hypertension. Systolic BP levels correlated significantly with GFRDTPA values despite the absence of hyperfiltration. Greater increase in GFR from initial TSC diagnosis till the age of the assessment, resulted in higher GFR levels in childhood and adolescence in those that developed hypertension and possibly in those with angiomyolipoma or cysts. All patients with ambulatory BP hypertension had angiomyolipomas or cysts on renal imaging studies. Conclusions Hypertension may present with increased frequency in young patients with kidney disease associated with TSC. Routine ambulatory BP measurement could be part of the annual clinical assessment in patients with TSC.


2020 ◽  
Vol 40 (2) ◽  
pp. 142-151
Author(s):  
Gema Ariceta ◽  
María José Buj ◽  
Mónica Furlano ◽  
Víctor Martínez ◽  
Anna Matamala ◽  
...  

2010 ◽  
Vol 257 (8) ◽  
pp. 1373-1381 ◽  
Author(s):  
Anne Gallagher ◽  
Ellen P. Grant ◽  
Neel Madan ◽  
Delma Y. Jarrett ◽  
David A. Lyczkowski ◽  
...  

2015 ◽  
Vol 121 (5) ◽  
pp. 402-408 ◽  
Author(s):  
Arthur Robert ◽  
Valerie Leroy ◽  
Audrey Riquet ◽  
Lucile Gogneaux ◽  
Nathalie Boutry ◽  
...  

Author(s):  
Michael Wong

Abstract Background Tuberous sclerosis complex (TSC) is a genetic disorder characterized by severe neurological manifestations, including epilepsy, intellectual disability, autism, and a range of other behavioral and psychiatric symptoms, collectively referred to as TSC-associated neuropsychiatric disorders (TAND). Various tumors and hamartomas affecting different organs are the pathological hallmarks of the disease, especially cortical tubers of the brain, but specific cellular and molecular abnormalities, such as involving the mechanistic target of rapamycin (mTOR) pathway, have been identified that also cause or contribute to neurological manifestations of TSC independent of gross structural lesions. In particular, while neurons are immediate mediators of neurological symptoms, different types of glial cells have been increasingly recognized to play important roles in the phenotypes of TSC. Main body This review summarizes the literature supporting glial dysfunction from both mouse models and clinical studies of TSC. In particular, evidence for the role of astrocytes, microglia, and oligodendrocytes in the pathophysiology of epilepsy and TAND in TSC is analyzed. Therapeutic implications of targeting glia cells in developing novel treatments for the neurological manifestations of TSC are also considered. Conclusions Different types of glial cells have both cell autonomous effects and interactions with neurons and other cells that are involved in the pathophysiology of the neurological phenotype of TSC. Targeting glial-mediated mechanisms may represent a novel therapeutic approach for epilepsy and TAND in TSC patients.


Sign in / Sign up

Export Citation Format

Share Document